Computer Vision: From Early Cancer Detection to Augmented Radiology

Introduction

Computer vision has revolutionized the medical field by providing powerful tools for the early detection of serious diseases. Thanks to artificial intelligence, diagnoses have become more accurate and faster.

This technological advance has enabled a significant transformation in the way healthcare professionals approach cancer screening and treatment. Today, we explore how these technologies have evolved and their impact on radiology.

In this article, we will examine the progress made in cancer detection, the key technologies used, and the outlook for the future.

Context and Evolution

The pioneers (2015-2020)

In the mid-2010s, computer vision began to emerge as a viable tool for medical applications. Early research focused on analyzing medical images to identify potentially cancerous anomalies.

Progress was rapid, with algorithms capable of surpassing the human eye in detecting certain pathologies. This paved the way for innovations that transformed clinical practice.

The pioneers of this period laid the foundations of what would become a revolution in medical diagnosis.

The post-COVID explosion (2020-2025)

The number of AI-based medical devices authorized by the FDA has grown sharply in recent years.

— FDA Digital Health Center of Excellence, 2024

The COVID-19 pandemic accelerated the adoption of digital technologies in the healthcare sector. Computer vision systems played a crucial role in managing the health crisis.

Hospitals quickly integrated AI to optimize screening and treatment operations. This period saw an exponential increase in the use of computer vision tools.

As a result, the capabilities of these systems improved considerably, enabling earlier and more reliable cancer detection.

Clinical Applications

Breast cancer detection

Breast cancer is one of the first pathologies to have benefited from advances in computer vision. Systems such as the mammographic screening model developed by Google Health or Lunit INSIGHT MMG (Lunit) analyze mammograms to detect tumors invisible to the naked eye.

On certain well-defined detection tasks, these systems match or exceed the performance of a radiologist working alone — the comparison depending heavily on the evaluation protocol. This has improved early detection rates and reduced the need for unnecessary biopsies.

AI systems achieve results comparable to, or even better than, those of radiologists working alone on targeted tasks.

— Nature Medicine, International Breast Cancer Study 2024

Lung cancer

Lung cancer, known for being difficult to detect early, has also benefited from technological advances. Solutions such as Aidoc or AI-Rad Companion (Siemens Healthineers) analyze chest scans to identify small lesions that may indicate early cancer.

These technologies have made it possible to reduce the false-negative rate, thus offering a more reliable and earlier diagnosis. This has a direct impact on patient survival rates.

By integrating AI into the screening process, practitioners can make more informed decisions and improve clinical outcomes.

Other applications

• Diabetic retinopathy
• Bone fractures
• Cardiac pathologies

Key Technologies

Convolutional neural networks (CNN)

Convolutional neural networks are at the heart of advances in computer vision. They enable the automatic extraction of complex features from medical images.

These networks are particularly effective at recognizing patterns in high-resolution images, such as scans and MRIs. This capability has been decisive in improving diagnostic accuracy.

CNNs continue to evolve, incorporating innovations such as regularization and transfer learning to improve their performance.

Vision Transformers (ViT)

More recently, Vision Transformers have emerged as a promising alternative to CNNs. They use attention mechanisms to analyze images as a whole, rather than focusing on specific parts.

This approach enables a better contextual understanding of images, which is crucial for accurate and rapid analysis. ViTs are redefining industry standards.

Their ability to process large amounts of data efficiently makes them a valuable tool for augmented radiology.

Players and Ecosystem

The market for AI in medical imaging is expanding rapidly, driven by successive regulatory approvals and integration into hospital workflows.

— Grand View Research, Market Analysis 2024

Technology giants

Companies such as Google Health, IBM Watson Health, and Microsoft play a key role in the development and implementation of computer vision technologies in the medical field.

These giants invest heavily in research and development to improve algorithms and prediction models. Their expertise in AI enables them to offer innovative and effective solutions.

Their collaboration with medical institutions and researchers has led to significant advances in the detection and treatment of diseases.

Innovative startups

Startups such as Aidoc, Zebra Medical, and Lunit bring new perspectives and solutions to the challenges of computer vision. Their agility and their ability to innovate quickly place them at the forefront of this revolution.

These companies often focus on specific niches, such as detecting rare pathologies or optimizing medical workflows. Their unique and specialized approach contributes to the rise of new clinical applications.

By collaborating with hospitals and research centers, they accelerate the adoption of AI in the medical sector.

Medical manufacturers

Medical manufacturers such as Siemens Healthineers, GE Healthcare, and Philips play a crucial role by integrating computer vision solutions into their diagnostic equipment.

These companies develop devices capable of capturing high-quality medical images, essential for accurate analysis. Their expertise in medical engineering makes it possible to combine hardware and software optimally.

Their commitment to innovation continues to drive the adoption of these technologies in healthcare facilities around the world.

Challenges and Ethical Issues

Algorithmic bias

One of the main challenges of computer vision is ensuring that algorithms do not reproduce the biases present in the training data. Particular attention must be paid to the diversity of the datasets used.

Biases can lead to erroneous diagnoses, mainly affecting underrepresented populations. Researchers and developers are working to mitigate these biases in order to guarantee the fairness of AI systems.

However, much remains to be done to fully understand the impact of these biases and to correct them effectively.

Regulation and certification

The regulation of medical devices incorporating AI is essential to ensure their safety and effectiveness. Health agencies, such as the FDA, have put in place regulatory frameworks to evaluate these technologies.

Certification processes can be long and complex, which can slow down innovation. Companies must navigate these regulations to bring their products to market.

Efforts are underway to harmonize regulatory processes on a global scale, thus facilitating the adoption of these technologies.

Acceptance by practitioners

The acceptance of computer vision technologies by healthcare professionals is crucial to their success. Practitioners must be convinced of the reliability and usefulness of these systems in order to integrate them into their practice.

Training and demonstrations of effectiveness are often necessary to overcome initial resistance. Collaboration between developers and healthcare professionals is essential to adapt the tools to clinical needs.

This transition is underway, with growing adoption of AI technologies in hospitals and clinics.

Outlook 2025-2030

AI-assisted radiological diagnosis is expected to become widespread in hospital facilities.

— McKinsey Global Institute, Healthcare AI Report 2024

The next five years should see an even broader adoption of computer vision technologies in radiology. AI systems will continue to improve, offering more accurate and personalized diagnoses.

Collaborations between technology companies, startups, and medical institutions will be key to developing new applications. This convergence of expertise will make it possible to accelerate innovation.

The evolution of regulations and the growing acceptance of AI by practitioners will contribute to establishing higher standards of care. These advances will transform the medical landscape for decades to come.

While computer vision is transforming medical imaging, artificial intelligence is advancing just as fast on the side of language and conversation. This is the field Koaee is working on: multilingual conversational assistants for businesses, in sixteen languages, with servers located in Europe and no conversations retained. Our assistants rely on cutting-edge technologies such as Voxtral (Mistral) and GPT (OpenAI).

Conclusion

Computer vision represents a turning point in the healthcare field, offering unprecedented means to improve the diagnosis and treatment of diseases. Its applications in early cancer detection and augmented radiology are already tangible.

As we move toward widespread adoption, the challenges related to bias, regulation, and acceptance by practitioners will need to be addressed. The outlook is promising, and the benefits for patients considerable.

Sources

• Nature Medicine - International evaluation of AI for breast cancer screening
• The Lancet Digital Health
• FDA - AI/ML Enabled Medical Devices
• Radiology - RSNA Journal
• Google Health - Medical Imaging